<bill session="115" type="h" number="4084" updated="2023-01-11T13:38:24Z">
  <state datetime="2017-10-19">REFERRED</state>
  <status>
    <introduced datetime="2017-10-19"/>
  </status>
  <introduced datetime="2017-10-19"/>
  <titles>
    <title type="display">To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.</title>
    <title type="official" as="introduced">To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.</title>
  </titles>
  <sponsor bioguide_id="K000382"/>
  <cosponsors>
    <cosponsor bioguide_id="C001068" joined="2017-12-01"/>
    <cosponsor bioguide_id="C000754" joined="2017-10-19"/>
    <cosponsor bioguide_id="D000617" joined="2017-12-01"/>
    <cosponsor bioguide_id="D000399" joined="2017-11-29"/>
    <cosponsor bioguide_id="E000293" joined="2017-11-29"/>
    <cosponsor bioguide_id="J000032" joined="2017-12-01"/>
    <cosponsor bioguide_id="J000297" joined="2017-10-19"/>
    <cosponsor bioguide_id="R000577" joined="2017-10-19"/>
  </cosponsors>
  <actions>
    <action datetime="2017-10-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-10-19" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-19">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-20">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-11-01">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="s" number="1960" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-07T22:13:25Z" status="Introduced in House">This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.</summary>
</bill>
